Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in the Company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | May 30, 2025 |
| Number of Shares Purchased | 797,519 |
| Highest Price Paid (p) | 419.30 |
| Lowest Price Paid (p) | 415.60 |
| Volume Weighted Average Price (p) | 417.45 |
| Registered Share Capital | 9,005,330,185 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,001,249,980 |
Material Changes
Following the settlement of the share purchase, the Company's registered share capital remains 9,005,330,185 ordinary shares. The number of shares held as treasury shares increased to 4,080,205, resulting in 9,001,249,980 ordinary shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction in accordance with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares purchased (797,519) and the weighted average price (417.45p) against the Company's full buyback programme progress.
- Confirm the updated count of voting shares (9,001,249,980) for disclosure threshold calculations under FCA rules.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution details.
- Note that this filing does not contain operational or financial performance data for the period.